Literature DB >> 28496717

Necessity of Repeat Ablations to Eliminate Atrial Fibrillation.

Stephanie Fichtner1, Gabriele Hessling1, Isabel Deisenhofer1.   

Abstract

Atrial fibrillation (AF) is the most common human arrhythmia and leads to increased morbidity and mortality. Because of demographic changes, the prevalence of AF will increase in the next decades, requiring better primary prevention strategies and better treatment options. In 1998, Haissaguerre et al. described triggering foci in the pulmonary veins (PV) as the prevailing pathophysiological initiator of paroxysmal AF. Since then, multiple studies have been conducted using the technique of pulmonary vein isolation (PVI) to eliminate AF. In short term follow-up, success rates of 60-75% in patients with paroxysmal AF are reached, with significantly worse results in persistent AF of approximately 50%. Due to arrhythmia recurrence, multiple procedures are often necessary, especially in patients with persistent AF, to achieve these results. It is supposed that the cause of arrhythmia recurrence is pulmonary vein reconnection in patients with paroxysmal AF, and insufficient substrate modification or new substrate development in patients with persistent AF. Future techniques like contact force control might improve lesion formation leading to improved PVI and substrate modification.

Entities:  

Year:  2012        PMID: 28496717      PMCID: PMC5153006          DOI: 10.4022/jafib.469

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  57 in total

1.  Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.

Authors:  Michel Haïssaguerre; Mélèze Hocini; Prashanthan Sanders; Frederic Sacher; Martin Rotter; Yoshihide Takahashi; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

2.  Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification.

Authors:  William H Sauer; Concepcion Alonso; Erica Zado; Joshua M Cooper; David Lin; Sanjay Dixit; Andrea Russo; Ralph Verdino; Sen Ji; Edward P Gerstenfeld; David J Callans; Francis E Marchlinski
Journal:  Circulation       Date:  2006-07-10       Impact factor: 29.690

3.  Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison.

Authors:  Stephan Willems; Hanno Klemm; Thomas Rostock; Benedikt Brandstrup; Rodolfo Ventura; Daniel Steven; Tim Risius; Boris Lutomsky; Thomas Meinertz
Journal:  Eur Heart J       Date:  2006-06-16       Impact factor: 29.983

4.  Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance.

Authors:  S Ernst; M Schlüter; F Ouyang; A Khanedani; R Cappato; J Hebe; M Volkmer; M Antz; K H Kuck
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

5.  Repeated provocation of time- and ATP-induced early pulmonary vein reconnections after pulmonary vein isolation: eliminating paroxysmal atrial fibrillation in a single procedure.

Authors:  Teiichi Yamane; Seiichiro Matsuo; Taro Date; Nicolas Lellouche; Mika Hioki; Ryosuke Narui; Keiichi Ito; Shin-ichi Tanigawa; Seigo Yamashita; Michifumi Tokuda; Hiroshi Yoshida; Keiichi Inada; Kenri Shibayama; Satoru Miyanaga; Hidekazu Miyazaki; Kunihiko Abe; Ken-ichi Sugimoto; Michihiro Yoshimura
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08-13

6.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

7.  Predictors of success after selective pulmonary vein isolation of arrhythmogenic pulmonary veins for treatment of atrial fibrillation.

Authors:  Edward P Gerstenfeld; William Sauer; David J Callans; Sanjay Dixit; David Lin; Andrea M Russo; Stuart Beldner; Melissa McKernan; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2006-02       Impact factor: 6.343

8.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

9.  Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique.

Authors:  Feifan Ouyang; Matthias Antz; Sabine Ernst; Hitoshi Hachiya; Hercules Mavrakis; Florian T Deger; Anselm Schaumann; Julian Chun; Peter Falk; Detlef Hennig; Xingpeng Liu; Dietmar Bänsch; Karl-Heinz Kuck
Journal:  Circulation       Date:  2004-12-27       Impact factor: 29.690

10.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.